AnaptysBio
Anaptys reports positive results for its rare skin disease drug and seeks a partner for commercialization
Anika Sharma
AnaptysBio has unveiled promising phase 3 data for its rare skin disease drug candidate, indicating a potential challenge to Boehringer ...
